Molecular cloning, expression, bioinformatics analysis, and bioactivity of TNFSF13 (APRIL) in the South African clawed frog (Xenopus laevi): A new model to study immunological diseases

OMICS A Journal of Integrative Biology

Volumn 17, Issue 7, 2013, Pages 384-392

  Liu, Xia ^a   Ji, Xue Mei ^a   Du, Xi Ning ^a   Zong, Xi Cui ^a   Liang, Ding Fang ^a   Ma, Li ^a   Wu, Hai Tao ^a   Zhang, Shuang Quan ^a  

^a NANJING NORMAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

APRIL PROTEIN; COMPLEMENTARY DNA; RECOMBINANT PROTEIN;

AFFINITY CHROMATOGRAPHY; ANIMAL CELL; ARTICLE; B LYMPHOCYTE; BIOINFORMATICS; CELL SURFACE; CELL SURVIVAL; CONFOCAL MICROSCOPY; ESCHERICHIA COLI; EXPERIMENTAL MODEL; GENE AMPLIFICATION; GENE EXPRESSION; GENE STRUCTURE; GENETIC CONSERVATION; HUMAN; LYMPHOCYTE PROLIFERATION; MOLECULAR BIOLOGY; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PURIFICATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING; XENOPUS LAEVIS;

AMINO ACID SEQUENCE; ANIMALS; B-CELL ACTIVATING FACTOR; B-LYMPHOCYTES; CELL PROLIFERATION; CELL SURVIVAL; CLONING, MOLECULAR; COMPUTATIONAL BIOLOGY; DNA, COMPLEMENTARY; ESCHERICHIA COLI; IMMUNE SYSTEM DISEASES; MICE; MOLECULAR SEQUENCE DATA; PHYLOGENY; PROTEIN BINDING; PROTEIN CONFORMATION; RECOMBINANT PROTEINS; SEQUENCE ALIGNMENT; TISSUE DISTRIBUTION; XENOPUS LAEVIS; XENOPUS PROTEINS;

EID: 84880107766     PISSN: 15362310     EISSN: 15578100     Source Type: Journal    
DOI: 10.1089/omi.2013.0004     Document Type: Article

References (32)

1. Ai HX, Shen YF, Min C, et al. (2011). Molecular structure, expression and bioactivity characterization of TNF13B (BAFF) gene in mefugu, Takifugu obscurus. Fish Shellfish Immunol 30, 1265-1247.
2. Bodmer JL, Schneider P, and Tschopp J. (2002). The molecular architecture of the TNF superfamily. Trends Biol Sci 27, 18-26.
3. Castigli E, Scott S, Dedeoglu F, and Bryce P. (2004. Impaired IgA class switching in APRIL-deficient mice. Proc Natl Acad Sci USA 101, 3903-3908.
4. Cui XW, Han YY, Pan YB, Xu XZ, Ren WH, and Zhang SQ. (2011). Molecular cloning, expression and functional analysis of interleukin-8 (IL-8) in South African clawed frog (Xenopus laevis). Development Compar Immunol 35, 1159-1165.
5. Dillon SR, Gross JA, Ansell SM, and Novak AJ. (2006). An APRIL to remember: Novel TNF ligands as therapeutic targets. Nat Rev Drug Discov 5, 235-246.
6. Gordon NC, Pan B, Hymowitz SG, et al. (2003). BAFF/BLyS receptor 3 comprises a minimal TNF receptor-like module that encodes a highly focused ligand-binding site. Biochemistry 42, 5977-5983.
7. Gurdon JB. (1996. Introductory comments - Xenopus as a laboratory animal. In: Tinsley, Kobel, Eds, Biology of Xenopus. Oxford University Press, Oxford, pp. 3-6.
8. Guan ZB, Shui Y, and Zhang SQ. (2007). Two related ligands of the TNF family, BAFF and APRIL, in rabbit: Molecular cloning, 3D modeling, and tissue distribution. Cytokine 39, 192- 200.
9. Hymowitz SG, Patel DR, Wallweber HJ, et al. (2005). Structures of APRIL-receptor complexes: Like BCMA, TACI employs only a single cysteine-rich domain for high affinity ligand binding. J Biol Chem 280, 7218-7227.
10. Hendriks J, Planelles L, de Jong-Odding J, et al. (2005). Heparan sulfate proteoglycan binding promotes APRIL-induced tumor cell proliferation. Cell Death Differ 12, 637-648.
11. Hahne M, Kataoka T, Schroüter M, et al. (1998). APRIL, a new ligand of the tumor necrosis factor family, stimulates tumor cell growth. J Exp Med 188, 1185-1190.
12. Jonsson MV, Szodoray P, Jellestad S, Jonsson R, and Skarstein K. (2005). Association between circulating levels of the novel TNF family members APRIL and BAFF and lymphoid organization in primary Sjogren's syndrome. J Clin Immunol 25, 189-201.
13. Kim HM, Yu KS, Lee ME, et al. (2003). Crystal structure of the BAFF-BAFF-R complex and its implications for receptor activation. Nature Struct Biol 10, 342-348.
14. Lopez-Fraga M, Fernandez R, Albar JP, and Hahne M. (2001). Biologically active APRIL is secreted following intracellular processing in the Golgi apparatus by furin convertase. EMBO Rep 2, 945-951.
15. Liu YF, Hong X, Kapple J, et al. (2003). Ligand-receptor binding revealed by the TNF family member TALL-1. Nature 423, 49-56.
16. Litinskiy MB, Nardelli B, Hilbert DM, et al. (2002). DCs induce CD40-independent immunoglobulin class switching through BLyS and APRIL. Nat Immunol 3, 822-829.
17. Locksley RM, Killeen N, and Lenardo MJ. (2001). The TNF and TNF receptor superfamilies: Integrating mammalian biology. Cell 104, 487-501.
18. Laabi Y, Gras MP, Brouet JC, Berger R, Larsen CJ, and Tsapis A. (1994). The BCMA gene, preferentially expressed during B lymphoid maturation, is bidirectionally transcribed. Nucleic Acids Res 22, 1147-1154.
19. Mackay F, and Leung H. (2006). The role of the BAFF/APRIL system on T cell function. Semin Immunol 18, 284-289.
20. Mackay F, Schneider P, Rennert P, and Browning J. (2003). BAFF and APRIL: A tutorial on B cell survival. Annu Rev. Immunol 21, 231-264.
21. Novak AJ, Darce JR, Arendt BK, et al. (2004). Expression of BCMA, TACI, and BAFF-R in multiple myeloma: A mechanism for growth and survival. Blood 103, 689-694.
22. O'Connor BP, Raman VS, Erickson LD, et al. (2004). BCMA is essential for the survival of long-lived bone marrow plasma cells. J Exp Med 199, 91-98.
23. Planelles L, Carvalho-Pinto CE, Hardenberg G, et al. (2004). APRIL promotes B-1 cell associated neoplasm. Cancer Cell 6, 399-408.
24. Patel DR, Wallweber HJA, Yin JP, et al. (2004). Engineering an APRIL-specific B cell maturation antigen. J Biol Chem 279, 16727-16735.
25. Rennert P, Schneider P, Cachero TG, et al. (2000). A soluble form of B cell maturation antigen, a receptor for the tumor necrosis factor family member APRIL, inhibits tumor cell growth. J Exp Med 192, 1677-1684.
26. Roth W, Wagenknecht B, Klumpp A, et al. (2001). APRIL, a new member of the tumor necrosis factor family, modulates death ligand-induced apoptosis. Cell Death Different 8, 403-410.
27. Smith CA, Farrah T, and Goodwin RG. (1994). The TNF receptor superfamily of cellular and viral proteins: Activation, costimulation, and death. Cell 76, 959-962.
28. Stein JV, López-Fraga M, Elustondo FA, et al. (2002) APRIL modulates B and T cell immunity. Am Soc Clin Investig 109, 1587-1598.
29. Tan SM, Xu D, Roschke V, et al. (2003). Local production of B lymphocyte stimulator protein and APRIL in arthritic joints of patients with inflammatory arthritis. Arthritis Rheum 48, 982-992.
30. Thangarajh M, Masterman T, Rot U, et al. (2005). Increased levels of APRIL (a proliferation- inducing ligand) mRNA in multiple sclerosis. J Neuroimmunol 167, 210-214.
31. You FT, Zhou LD, Liu XX, Fan J, Ke Z, and Ren WH. (2012). Molecular structure, expression analysis and functional characterization of APRIL (TNFSF13) gene in bat (Vespertilio superans Thomas). Gene 498, 196-202.
32. Yu G, Boone T, Delaney J, et al. (2000). APRIL and TALL-I and receptors BCMA and TACI: System for regulating humoral immunity. Nat Immunol 1, 252-256 Higher Education Institutions